Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-20T06:10:40.068Z Has data issue: false hasContentIssue false

Chapter 2 - Evaluation of the Patient with Parkinson’s Disease in the Early Stages: Non-Motor Phase

Published online by Cambridge University Press:  05 March 2022

By
Anna Sauerbier ,
Daniele Urso ,
Chloe Farrell ,
K. Ray Chaudhuri  and
Carmen Rodriguez-Blazquez
Edited by
Néstor Gálvez-Jiménez ,
Amos D. Korczyn  and
Ramón Lugo-Sanchez
Néstor Gálvez-Jiménez
Affiliation:
Florida International University
Amos D. Korczyn
Affiliation:
Tel-Aviv University
Ramón Lugo-Sanchez
Affiliation:
Cleveland Clinic
Get access

Summary

Value based healthcare is a key aspect of modern healthcare delivery. Outcome measures are therefore a major aspect of addressing the importance of healthcare delivery and the objectives it aims to achieve. Besides motor symptoms, non-motor symptoms (NMS) in Parkinson’s disease (PD) drive quality of life across all stages of the disease, as well as societal costs. Objective measurement is possible using validated tools, both patient self-rated and healthcare professional-administered. Mixed motor and non-motor objective assessments are therefore recommended in order to achieve an adequate evaluation and management tailored to the patients’ specific needs [1]. Furthermore, the availability of assessment instruments for detecting and measuring NMS has allowed understanding of their importance, progression, and impact on the patients’ daily life, and the estimation of the effect of interventions in PD patients [2].

Type
Chapter
Information
Non-motor Parkinson's Disease , pp. 18 - 26
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Martinez-Martin, P, Chaudhuri, K. Ray., Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need. Expert Rev Neurother 2018; 18(1): 41–50.CrossRefGoogle ScholarPubMed
Martinez-Martin, P, et al. Measurement of nonmotor symptoms in clinical practice. Int Rev Neurobiol 2017; 133: 291–345.CrossRefGoogle ScholarPubMed
Schapira, AHV, Chaudhuri, KR, Jenner, P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017; 18(8): 509.Google Scholar
Chaudhuri, KR, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 2006; 21(7): 916–923.Google Scholar
Chaudhuri, KR, et al. The burden of non-motor symptoms in Parkinson’s disease using a self-completed non-motor questionnaire: a simple grading system. Parkinsonism Relat Disord 2015; 21(3): 287–291.CrossRefGoogle ScholarPubMed
Gunther, R, et al. Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol 2016; 7: 117.CrossRefGoogle ScholarPubMed
Sauerbier, A, et al. Restless legs syndrome – the under-recognised non-motor burden: a questionnaire-based cohort study. Postgrad Med 2019; 131(7): 473–478.CrossRefGoogle Scholar
Dafsari, HS, et al. Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson’s disease. Brain Stimul 2016; 9(1): 78–85.CrossRefGoogle ScholarPubMed
NICE. Parkinson’s Disease in Adults. NICE Guidelines. 2017: 23.Google Scholar
Chaudhuri, KR, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 2007; 22(13): 1901–1911.CrossRefGoogle ScholarPubMed
Ray Chaudhuri, K., et al. A proposal for a comprehensive grading of Parkinson’s disease severity combining motor and non-motor assessments: meeting an unmet need. PloS One 2013; 8(2): e57221–e57221.Google Scholar
Storch, A, et al. Non-motor Symptoms Questionnaire and Scale for Parkinson’s disease. Cross-cultural adaptation into the German language. Nervenarzt 2010; 81(8): 980–985.Google Scholar
Cova, I, et al. Validation of the Italian version of the Non-Motor Symptoms Scale for Parkinson’s disease. Parkinsonism Relat Disord 2017; 34: 38–42.Google Scholar
Sauerbier, A, et al. A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implication for non-motor studies in Parkinson’s disease. Mov Disord 2017; 32.Google Scholar
Chaudhuri, KR, et al. The movement disorder society nonmotor rating scale: Initial validation study. Mov Disord 2020; 35(1): 116–133.CrossRefGoogle ScholarPubMed
Goetz, CG, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007; 22(1): 41–47.CrossRefGoogle ScholarPubMed
Fahn, S, Elton, R, U.D. Committee. The Unified Parkinson’s Disease Rating Scale. In: Fahn, S, Marsden, CD, Calne, DB, Goldstein, M (eds). Recent Developments in Parkinson’s Disease, 2nd ed.Macmillan Healthcare Information; 1987, 153–163, 293–304.Google Scholar
Gallagher, DA, et al. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson’s disease. Mov Disord 2012; 27(1): 79–83.CrossRefGoogle ScholarPubMed
Goetz, CG, et al. IPMDS-sponsored scale translation program: process, format, and clinimetric testing plan for the MDS-UPDRS and UDysRS. Mov Disord Clin Pract 2014; 1(2): 97–101.Google Scholar
Goetz, CG, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23(15): 2129–2170.Google Scholar
Martinez-Martin, P, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). J Neurol 2013; 260(1): 228–236.CrossRefGoogle ScholarPubMed
Antonini, A, et al. Validation of the Italian version of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale. Neurol Sci 2013; 34(5): 683–687.CrossRefGoogle ScholarPubMed
Melzack, R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1(3): 277–299.CrossRefGoogle ScholarPubMed
Cleeland, C. Measurement of pain by subjective report. In: Chapman, CR, Loeser, JD, (eds.). Issues in Pain Measurement, 1st ed. Raven; 1989, 391–403.Google Scholar
Bouhassira, D, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004; 108(3): 248–257.Google Scholar
Perez-Lloret, S, et al. Rating scales for pain in Parkinson’s disease: critique and recommendations. Mov Disord Clin Pract 2016; 3(6): 527–537.Google Scholar
Chaudhuri, KR, et al. King’s Parkinson’s disease pain scale, the first scale for pain in PD: An international validation. Mov Disord 2015; 30(12): 1623–1631.CrossRefGoogle ScholarPubMed
Trenkwalder, C, et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol 2013; 12(12): 1141–1150.CrossRefGoogle ScholarPubMed
Rascol, O, et al. A randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson’s disease-associated chronic pain. J Clin Pharmacol 2016; 56(7): 852–861.Google Scholar
Silverdale, MA, et al. A detailed clinical study of pain in 1957 participants with early/moderate Parkinson’s disease. Parkinsonism Relat Disord 2018; 56: 27–32.Google Scholar
Marinus, J, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75(3): 388–395.Google Scholar
Chaudhuri, KR, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002; 73(6): 629–635.CrossRefGoogle Scholar
Trenkwalder, C, et al. Parkinson’s disease sleep scale–validation of the revised version PDSS-2. Mov Disord 2011; 26(4): 644–652.Google Scholar
Kurtis, MM, et al. A review of scales to evaluate sleep disturbances in movement disorders. Front Neurol 2018; 9: 369.Google Scholar
Hogl, B, et al. Scales to assess sleep impairment in Parkinson’s disease: critique and recommendations. Mov Disord 2010; 25(16): 2704–2716.Google Scholar
Fernandez-Pajarin, G, et al. Evaluating the efficacy of nocturnal continuous subcutaneous apomorphine infusion in sleep disorders in advanced Parkinson’s disease: the APO-NIGHT study. J Parkinsons Dis 2016; 6(4): 787–792.CrossRefGoogle ScholarPubMed
Patel, N, et al. Nighttime sleep and daytime sleepiness improved with pimavanserin during treatment of Parkinson’s disease psychosis. Clin Neuropharmacol 2018; 41(6): 210–215.Google Scholar
Fei, L, Zhou, D, Ding, ZT. The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson’s disease: a meta-analysis. Sleep Med 2019; 61: 19–25.Google Scholar
Stefansdottir, S, et al. Subjective sleep problems in patients with early Parkinson’s disease. Eur J Neurol 2012; 19(12): 1575–1581.Google Scholar
Bušková, J, et al. Sleep disturbances in untreated Parkinson’s disease. J Neurol 2011; 258(12): 2254–2259.Google Scholar
Happe, S, et al. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson’s disease. J Neurol 2007; 254(8): 1037–1043.Google Scholar
Dhawan, V, et al. The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurol Sci 2006; 248(1–2): 158–162.Google Scholar
Suzuki, K, et al. Evaluation of cutoff scores for the Parkinson’s disease sleep scale-2. Acta Neurol Scand 2015; 131(6): 426–430.Google Scholar
Muntean, ML, et al. Clinically relevant cut-off values for the Parkinson’s Disease Sleep Scale-2 (PDSS-2): a validation study. Sleep Med 2016; 24: 87–92.Google Scholar
Trenkwalder, C, et al. Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 2011; 26(1): 90–99.CrossRefGoogle ScholarPubMed
Martinez-Martin, P, et al. The Parkinson’s Disease Sleep Scale-2 (PDSS-2): validation of the Spanish version and its relationship with a roommate-based version. Mov Disord Clin Pract 2019; 6(4): 294–301.CrossRefGoogle ScholarPubMed
Liu, H, et al. Rapid eye movement behavior disorder in drug-naïve patients with Parkinson’s disease. J Clin Neurosci 2019; 59: 254–258.Google Scholar
Evatt, ML, et al. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation–critique and recommendations by Movement Disorders Task Force on rating scales for Parkinson’s disease. Mov Disord 2009; 24(5): 635–646.Google Scholar
Pavy-Le Traon, A, et al. The Movement Disorders Task Force review of dysautonomia rating scales in Parkinson’s disease with regard to symptoms of orthostatic hypotension. Mov Disord 2011; 26(11): 1985–1992.Google Scholar
Visser, M, et al. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 2004; 19(11): 1306–1312.Google Scholar
Ashraf-Ganjouei, A, et al. Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease. PeerJ 2018; 6: e5539.Google Scholar
Stanković, I, et al. Longitudinal assessment of autonomic dysfunction in early Parkinson’s disease. Parkinsonism Relat Disord 2019; 66: 74–79.Google Scholar
Jones, JD, et al. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson’s disease. Parkinsonism Relat Disord 2020; 72: 7–12.Google Scholar
Friedman, JH, et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson’s disease. Mov Disord 2010; 25(7): 805–822.Google Scholar
Brown, RG, et al. The Parkinson fatigue scale. Parkinsonism Relat Disord 2005; 11(1): 49–55.Google Scholar
Nilsson, MH, Bladh, S, Hagell, P. Fatigue in Parkinson’s disease: measurement properties of a generic and a condition-specific rating scale. J Pain Symptom Manage 2013; 46(5): 737–746.Google Scholar
Stocchi, F. Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson’s disease. Eur J Neurol 2014; 21(2): 357–360.Google Scholar
Fernandez, HH, et al. Scales to assess psychosis in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23(4): 484–500.CrossRefGoogle ScholarPubMed
Schrag, A, et al. Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2007; 22(8): 1077–1092.Google Scholar
Leentjens, AF, et al. Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23(14): 2015–2025.Google Scholar
Evans, AH, et al. Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: critique and recommendations. Mov Disord 2019; 34(6): 791–798.Google Scholar
Leentjens, AF, et al. The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale. Mov Disord 2014; 29(8): 1035–1043.Google Scholar
Santangelo, G, et al. Anxiety in early Parkinson’s disease: validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS). J Neurol Sci 2016; 367: 158–161.Google Scholar
Leentjens, AF, et al. Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23(14): 2004–2014.Google Scholar
Starkstein, SE, et al. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1992; 4(2): 134–139.Google Scholar
Pedersen, KF, et al. Psychometric properties of the Starkstein Apathy Scale in patients with early untreated Parkinson disease. Am J Geriatr Psychiatry 2012; 20(2): 142–148.CrossRefGoogle ScholarPubMed
Terashi, H, et al. Characteristics of apathy in treatment-naïve patients with Parkinson’s disease. Int J Neurosci 2019; 129(1): 16–21.Google Scholar
Siciliano, M, et al. Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients. Parkinsonism Relat Disord 2017; 45: 63–68.CrossRefGoogle ScholarPubMed
Sawada, H, Oeda, T. Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson’s disease (EDAP). BMJ Open 2013; 3(9): e003533.Google Scholar
Rieu, I, et al. International validation of a behavioral scale in Parkinson’s disease without dementia. Mov Disord 2015; 30(5): 705–713.Google Scholar
Visser, M, et al. Assessment of psychiatric complications in Parkinson’s disease: the SCOPA-PC. Mov Disord 2007; 22(15): 2221–2228.Google Scholar
Martinez-Martin, P, et al. A short scale for evaluation of neuropsychiatric disorders in Parkinson’s disease: first psychometric approach. J Neurol 2012; 259(11): 2299–2308.CrossRefGoogle Scholar
Chaudhuri, KR, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25(6): 704–709.CrossRefGoogle Scholar
https://www.movementdisorders.org/MDS/MDS-Rating-Scales/MDS-Unified-Parkinsons-Disease-Rating-Scale-MDS-UPDRS.htm. Assessed on 25.08.2021.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×